Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
Objectives Ocular pain is a commonly reported finding in the intravitreal injection procedure, but post-injection experiences and patient adherence to treatment remain underexplored. We therefore aimed to identify key variations in the intravitreal injection procedure that may influence pain, and to...
Main Authors: | Heather Waterman, Sanjiv Banerjee, Christina Yiallouridou, Jennifer H Acton, Ashley Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-08-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/8/e069625.full |
Similar Items
-
Efficiency of Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
by: Didem sahin, et al.
Published: (2015-12-01) -
Intravitreal injections to prevent blindness due to wet type age-related macular degeneration
by: Elina C. Pérez Molina, et al.
Published: (2012-07-01) -
Preliminary study of Conbercept injected intravitreally for the treatment of wet age-related macular degeneration
by: Ying Qin, et al.
Published: (2017-08-01) -
Cost-effectiveness of intravitreal therapy in Age-Related Macular Degeneration
by: Piergiorgio Neri, et al.
Published: (2014-12-01) -
Comparison of clinical efficacy of intravitreal injection of Conbercept and Aflibercept in the treatment of wet age-related macular degeneration
by: Ping-Sun Yang, et al.
Published: (2023-04-01)